These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 27388736

  • 1. The Demise of the Bull's Eye (Screening for Hydroxychloroquine Retinopathy).
    Marmor MF.
    Retina; 2016 Oct; 36(10):1803-5. PubMed ID: 27388736
    [No Abstract] [Full Text] [Related]

  • 2. Hydroxychloroquine Screening Alert: Change is in the Wind.
    Marmor MF.
    Ophthalmic Surg Lasers Imaging Retina; 2017 Feb 01; 48(2):96-98. PubMed ID: 28195610
    [Abstract] [Full Text] [Related]

  • 3. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy.
    Michaelides M, Stover NB, Francis PJ, Weleber RG.
    Arch Ophthalmol; 2011 Jan 01; 129(1):30-9. PubMed ID: 21220626
    [Abstract] [Full Text] [Related]

  • 4. Current opinion on hydroxychloroquine-related retinal toxicity screening: where do we stand now?
    Aduriz-Lorenzo PM, Aduriz-Llaneza P, Araiz-Iribarren J, Khamashta MA.
    Lupus; 2020 Jun 01; 29(7):671-675. PubMed ID: 32316844
    [Abstract] [Full Text] [Related]

  • 5. Night Blindness, Ring Scotoma, and a Nonrecordable Electroretinogram in an Elderly Woman.
    Grassi MA, Maker MP, Marmor MF.
    JAMA Ophthalmol; 2019 Jan 01; 137(1):109-110. PubMed ID: 30452517
    [No Abstract] [Full Text] [Related]

  • 6. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.
    Melles RB, Marmor MF.
    JAMA Ophthalmol; 2014 Dec 01; 132(12):1453-60. PubMed ID: 25275721
    [Abstract] [Full Text] [Related]

  • 7. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy.
    Leung LS, Neal JW, Wakelee HA, Sequist LV, Marmor MF.
    Am J Ophthalmol; 2015 Oct 01; 160(4):799-805.e1. PubMed ID: 26189086
    [Abstract] [Full Text] [Related]

  • 8. New trends in early diagnosis of hydroxychloroquine toxic retinopathy.
    Vanderzee G, Tassi D.
    Optometry; 2012 May 31; 83(5):200-7. PubMed ID: 23249122
    [Abstract] [Full Text] [Related]

  • 9. Ocular toxicity of hydroxychloroquine.
    Tehrani R, Ostrowski RA, Hariman R, Jay WM.
    Semin Ophthalmol; 2008 May 31; 23(3):201-9. PubMed ID: 18432546
    [Abstract] [Full Text] [Related]

  • 10. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy.
    Marmor MF, Melles RB.
    Ophthalmology; 2014 Jun 31; 121(6):1257-62. PubMed ID: 24439759
    [Abstract] [Full Text] [Related]

  • 11. Hydroxychloroquine retinopathy: A review of imaging.
    Pandya HK, Robinson M, Mandal N, Shah VA.
    Indian J Ophthalmol; 2015 Jul 31; 63(7):570-4. PubMed ID: 26458473
    [Abstract] [Full Text] [Related]

  • 12. Case Report: Hydroxychloroquine Retinopathy.
    Eldeeb M, Chan EW, Omar A.
    Optom Vis Sci; 2018 Jun 31; 95(6):545-549. PubMed ID: 29787487
    [Abstract] [Full Text] [Related]

  • 13. High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy.
    Rodriguez-Padilla JA, Hedges TR, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG.
    Arch Ophthalmol; 2007 Jun 31; 125(6):775-80. PubMed ID: 17562988
    [Abstract] [Full Text] [Related]

  • 14. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
    Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology.
    Ophthalmology; 2011 Feb 31; 118(2):415-22. PubMed ID: 21292109
    [Abstract] [Full Text] [Related]

  • 15. AIMING FOR THE BULL'S EYE: The Cost-Utility of Screening for Hydroxychloroquine Retinopathy.
    McClellan AJ, Chang JS, Smiddy WE.
    Retina; 2016 Oct 31; 36(10):1958-63. PubMed ID: 27465574
    [Abstract] [Full Text] [Related]

  • 16. Effect of disease stage on progression of hydroxychloroquine retinopathy.
    Marmor MF, Hu J.
    JAMA Ophthalmol; 2014 Sep 31; 132(9):1105-12. PubMed ID: 24922444
    [Abstract] [Full Text] [Related]

  • 17. Hydroxychloroquine retinopathy.
    Maturi RK, Folk JC, Nichols B, Oetting TT, Kardon RH.
    Arch Ophthalmol; 1999 Sep 31; 117(9):1262-3. PubMed ID: 10496407
    [No Abstract] [Full Text] [Related]

  • 18. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging.
    Mititelu M, Wong BJ, Brenner M, Bryar PJ, Jampol LM, Fawzi AA.
    JAMA Ophthalmol; 2013 Sep 31; 131(9):1187-97. PubMed ID: 23887202
    [Abstract] [Full Text] [Related]

  • 19. Perifoveal interdigitation zone loss in hydroxychloroquine toxicity leads to subclinical bull's eye lesion appearance on near-infrared reflectance imaging.
    Chew AL, Sampson DM, Chelva E, Khan JC, Chen FK.
    Doc Ophthalmol; 2018 Feb 31; 136(1):57-68. PubMed ID: 29124422
    [Abstract] [Full Text] [Related]

  • 20. Value of red targets and pattern deviation plots in visual field screening for hydroxychloroquine retinopathy.
    Marmor MF, Chien FY, Johnson MW.
    JAMA Ophthalmol; 2013 Apr 31; 131(4):476-80. PubMed ID: 23710501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.